Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.0500 (-3.35%) ($5.0050 - $5.1500) on Thu. Jul. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.25% (three month average) | RSI | 67 | Latest Price | $5.0500(-3.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.9% a day on average for past five trading days. | Weekly Trend | BCRX advances 3.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) VIXM(6%) DRIV(4%) BND(3%) BNDX(3%) GLD(3%) | Factors Impacting BCRX price | BCRX will decline at least -3.625% in a week (0% probabilities). XLV(-9%) IWF(-8%) IVW(-8%) SPY(-7%) SPLV(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.625% (StdDev 7.25%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.18(-2.51%) | 10 Day Moving Average | $5.22(-3.26%) | 20 Day Moving Average | $4.86(3.91%) | To recent high | -9.6% | To recent low | 0.7% | Market Cap | $891m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |